Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3647 USD | +0.19% | -4.28% | -20.73% |
Financials (USD)
Sales 2024 * | 2.4M | Sales 2025 * | 11M | Capitalization | 27.02M |
---|---|---|---|---|---|
Net income 2024 * | -88M | Net income 2025 * | -86M | EV / Sales 2024 * | 1.9 x |
Net cash position 2024 * | 22.46M | Net cash position 2025 * | 49.7M | EV / Sales 2025 * | -2.06 x |
P/E ratio 2024 * |
-0.31
x | P/E ratio 2025 * |
-0.33
x | Employees | 255 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.55% |
Latest transcript on Singular Genomics Systems, Inc.
1 day | +0.19% | ||
1 week | -4.28% | ||
1 month | -10.42% | ||
3 months | -39.67% | ||
6 months | -12.54% | ||
Current year | -20.73% |
Managers | Title | Age | Since |
---|---|---|---|
Eli Glezer
FOU | Founder | 55 | 16-05-31 |
Andrew Spaventa
CEO | Chief Executive Officer | 39 | 16-05-31 |
Dalen Meeter
DFI | Director of Finance/CFO | 46 | 19-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Barker
FOU | Founder | 82 | 16-08-31 |
Kim Kamdar
BRD | Director/Board Member | 56 | 17-04-30 |
Michael Pellini
BRD | Director/Board Member | 58 | 17-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 9 M€ | +9.86% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.3647 | +0.19% | 69,172 |
24-05-30 | 0.364 | -2.15% | 81,242 |
24-05-29 | 0.372 | -0.80% | 108,013 |
24-05-28 | 0.375 | -1.57% | 83,205 |
24-05-24 | 0.381 | +2.97% | 48,008 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.73% | 27.02M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- OMIC Stock